Cargando…
First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399434/ https://www.ncbi.nlm.nih.gov/pubmed/32802455 http://dx.doi.org/10.21037/jtd-20-1882 |
_version_ | 1783566148239884288 |
---|---|
author | Jia, Ziqi Wang, Yanyu Cao, Lei Wang, Yadong Song, Yang Yang, Xiaoying Bing, Zhongxing Cao, Zhili Liu, Peng Zhang, Shuyang Chen, Zexin Huang, Min Yu, Yan Han-Zhang, Han Song, Jinlei Christoph, Daniel C. Passaro, Antonio Gridelli, Cesare Hishida, Tomoyuki Liang, Naixin Li, Shanqing |
author_facet | Jia, Ziqi Wang, Yanyu Cao, Lei Wang, Yadong Song, Yang Yang, Xiaoying Bing, Zhongxing Cao, Zhili Liu, Peng Zhang, Shuyang Chen, Zexin Huang, Min Yu, Yan Han-Zhang, Han Song, Jinlei Christoph, Daniel C. Passaro, Antonio Gridelli, Cesare Hishida, Tomoyuki Liang, Naixin Li, Shanqing |
author_sort | Jia, Ziqi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7399434 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-73994342020-08-13 First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up Jia, Ziqi Wang, Yanyu Cao, Lei Wang, Yadong Song, Yang Yang, Xiaoying Bing, Zhongxing Cao, Zhili Liu, Peng Zhang, Shuyang Chen, Zexin Huang, Min Yu, Yan Han-Zhang, Han Song, Jinlei Christoph, Daniel C. Passaro, Antonio Gridelli, Cesare Hishida, Tomoyuki Liang, Naixin Li, Shanqing J Thorac Dis iMDT Corner AME Publishing Company 2020-07 /pmc/articles/PMC7399434/ /pubmed/32802455 http://dx.doi.org/10.21037/jtd-20-1882 Text en 2020 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | iMDT Corner Jia, Ziqi Wang, Yanyu Cao, Lei Wang, Yadong Song, Yang Yang, Xiaoying Bing, Zhongxing Cao, Zhili Liu, Peng Zhang, Shuyang Chen, Zexin Huang, Min Yu, Yan Han-Zhang, Han Song, Jinlei Christoph, Daniel C. Passaro, Antonio Gridelli, Cesare Hishida, Tomoyuki Liang, Naixin Li, Shanqing First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up |
title | First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up |
title_full | First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up |
title_fullStr | First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up |
title_full_unstemmed | First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up |
title_short | First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up |
title_sort | first-line treatment selection with organoids of an egfrm + tp53m stage ia1 patient with early metastatic recurrence after radical surgery and follow-up |
topic | iMDT Corner |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399434/ https://www.ncbi.nlm.nih.gov/pubmed/32802455 http://dx.doi.org/10.21037/jtd-20-1882 |
work_keys_str_mv | AT jiaziqi firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT wangyanyu firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT caolei firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT wangyadong firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT songyang firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT yangxiaoying firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT bingzhongxing firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT caozhili firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT liupeng firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT zhangshuyang firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT chenzexin firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT huangmin firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT yuyan firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT hanzhanghan firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT songjinlei firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT christophdanielc firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT passaroantonio firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT gridellicesare firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT hishidatomoyuki firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT liangnaixin firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup AT lishanqing firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup |